FDA Clears Align Tech's Invisalign For Treatment With Mandibular Advancement

(RTTNews) - Align Technology Inc. (ALGN) Monday said the U.S. Food and Drug Administration has cleared Invisalign treatment with mandibular advancement for commercial availability in the U.S.

Invisalign treatment with mandibular advancement is the first clear aligner solution for Class II correction in growing tween and teen patients that combines the benefits of the most advanced clear aligner system in the world with features for moving the lower jaw forward while simultaneously aligning the teeth.

"Class II malocclusion is the largest opportunity in the teen segment, representing close to 45% of the 9 million teen case starts worldwide each year," said Raphael Pascaud, Align Technology chief marketing officer. "We believe that Invisalign treatment with mandibular advancement offers significant benefits to both doctors and their patients and is an effective alternative for Class II elastics and other traditional functional appliances like twin blocks".

In Class II treatments, doctors align the teeth and advance the lower jaw to improve the patient's profile.